ALPS Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,993
| Closed | -$338K | – | 994 |
|
|
2024
Q3 | $338K | Sell |
54,993
-311
| -0.6% | -$1.91K | ﹤0.01% | 903 |
|
|
2024
Q2 | $368K | Buy |
+55,304
| New | +$368K | ﹤0.01% | 690 |
|
|
2023
Q4 | – | Sell |
-38,878
| Closed | -$101K | – | 963 |
|
|
2023
Q3 | $101K | Buy |
38,878
+2,645
| +7% | +$6.88K | ﹤0.01% | 970 |
|
|
2023
Q2 | $128K | Buy |
36,233
+3,768
| +12% | +$13.3K | ﹤0.01% | 985 |
|
|
2023
Q1 | $137K | Sell |
32,465
-860
| -3% | -$3.63K | ﹤0.01% | 992 |
|
|
2022
Q4 | $548K | Buy |
33,325
+6,546
| +24% | +$108K | ﹤0.01% | 573 |
|
|
2022
Q3 | $342K | Buy |
26,779
+1,142
| +4% | +$14.6K | ﹤0.01% | 678 |
|
|
2022
Q2 | $300K | Sell |
25,637
-15,199
| -37% | -$178K | ﹤0.01% | 806 |
|
|
2022
Q1 | $249K | Sell |
40,836
-5,148
| -11% | -$31.4K | ﹤0.01% | 789 |
|
|
2021
Q4 | $421K | Sell |
45,984
-2,465
| -5% | -$22.6K | ﹤0.01% | 608 |
|
|
2021
Q3 | $548K | Sell |
48,449
-2,124
| -4% | -$24K | 0.01% | 486 |
|
|
2021
Q2 | $498K | Sell |
50,573
-16,627
| -25% | -$164K | ﹤0.01% | 517 |
|
|
2021
Q1 | $950K | Buy |
67,200
+7,725
| +13% | +$109K | 0.01% | 403 |
|
|
2020
Q4 | $671K | Buy |
+59,475
| New | +$671K | 0.01% | 441 |
|